Imatib (Imatinib) Tablet is a prescription medicine used in the treatment of certain types of cancers, including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GISTs). It belongs to the tyrosine kinase inhibitor (TKI) class of drugs that block abnormal proteins and prevent cancer cells from multiplying. Trusted resources like the Mayo Clinic and FDA provide detailed guidance on its approved uses.
Key Benefits & Uses
-
Effective in treating CML, ALL, GIST, and other rare cancers.
-
Helps slow cancer progression by targeting specific cancer cells.
-
Improves long-term survival rates in leukemia patients.
-
Oral administration makes it convenient compared to injections.
-
Backed by clinical evidence from studies available on PubMed.
How to Use
-
Take Imatib exactly as prescribed by your doctor.
-
Usually taken once or twice daily with a glass of water and food.
-
Do not crush or chew the tablet.
-
Consistency is key—take it at the same time daily.
-
For detailed dosage information, consult Drugs.com or your healthcare provider.
Important Safety Information
-
Regular blood tests are required to monitor your response.
-
Avoid grapefruit juice, which may interfere with the drug’s absorption.
-
Inform your doctor about liver, kidney, or heart problems before starting.
-
Pregnant or breastfeeding women should avoid use—refer to WHO for global safety guidelines.
Common Side Effects
-
Nausea, vomiting, diarrhea
-
Muscle cramps and joint pain
-
Swelling around eyes or ankles
-
Fatigue and headache
-
Rare but serious side effects should be reported immediately. Learn more from WebMD and Healthline.
Why Choose Imatib (Imatinib) Tablet?
-
Clinically proven effectiveness in blood cancers and tumors.
-
Endorsed by leading health organizations and approved by the FDA.
-
Backed by decades of research and global use.
-
Oral therapy improves patient compliance and comfort.

